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There is evidence that in non-diabetic people depression is associated with an elevati-
on of circulating levels of inflammatory markers. Cross-sectionally, this study examines 
if high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, IL-18, IL-1 receptor ant-
agonist (IL-1RA), monocyte chemotactic protein (MCP)-1 and adiponektin are associa-
ted with depression at baseline in people with diabetes. Longitudinally, this study also 
analyzes if a significantly improved depression score after a 12 month follow-up was 
associated with a reduction in the systemic inflammatory markers mentioned above. 
At baseline and at the 12 month follow-up 132 people with diabetes and subthreshold 
depression completed a depression questionnaire (CES-D). A significant improvement 
of depression was operationalized as a reduction by 9.1 points of the depression score 
(reliable change index). At both measurement points blood samples for the determina-
tion of the systemic inflammatory markers were drawn and analyzed in a central labo-
ratory using the same assays and plates for baseline as well as for follow-up samples. 
The multivariate analysis was adjusted for age, sex, BMI, HbA1c, diabetes type, mac-
rovascular disease and medication intake (statins, NSAID, anti-coagulant drugs, thyro-
id medication). Pre-post data were available for 132 people with diabetes (age 44.5 ± 
13.7 yrs., 44.1 % female, HbA1c 8.8 ± 1.7%, 64.1% type 1 diabetes, CES-D score 23.4 ± 
8.0). At baseline IL-1RA was significantly correlated with the depression score (ß=0.135, 
p=0.026). Patients with a significant reduction of their depression score at the 12 month 
follow-up had significant lower IL-1RA (396 ± 51 vs. 540 ± 32 pg/ml; p=0.034) and IL-18 
serum levels (270 ± 29 vs. 337 ± 19 pg/ml; p=0.023). In addition, there was a significant 
interaction effect between IL-1RA reduction and diabetes type (more pronounced re-
duction in type-2-diabetes).In the cross-sectional as well as in the longitudinal respon-
der analyses, IL-1RA levels showed a significant association with elevated depression 
scores as well as with the reduction of depression scores. In addition, people with a sig-
nificant reduction of their depression score had a significant lower IL-18 level at follow-
up. Besides lifestyle factors, adherence and glycemic control, systemic inflammatory 
processes involving cytokines of the IL-1 family might present a mediating mechanism 
between depression and the prognosis of diabetes.
Supported by ‘Competence Network for Diabetes mellitus’ funded by the BMBF (FKZ 
01GI1107) 
A B S T R A C T
• There is evidence that in non-diabetic people depression is associa-
ted with an elevation of circulating levels of inflammatory markers. 
• Cross-sectionally, this study examines if high-sensitivity C-reactive 
protein (hsCRP), interleukin (IL)-6, IL-18, IL-1 receptor antagonist 
(IL-1RA), monocyte chemotactic protein (MCP)-1 and adiponektin 
are associated with depression at baseline in people with diabetes. 
• Longitudinally, this study also analyzes if a significantly improved 
depression score after a 12 month follow-up was associated with a 
reduction in the systemic inflammatory markers mentioned above. 
I N T R O D U C T I O N
R E S U L T S
• Pre-post data were available for 132 people with diabetes. Table 1 
describes the baseline characteristics. 
• At baseline IL-1RA was significantly correlated with the depression 
score (ß=0.135, p=0.026). 
• Patients with a significant reduction of their depression score at 
the 12 month follow-up had significant lower IL-1RA (396 ± 51 vs. 
540 ± 32 pg/ml; p=0.034) and IL-18 serum levels (270 ± 29 vs. 337 
± 19 pg/ml; p=0.023) (see figure 2). 
• In addition, there was a significant interaction effect between IL-
1RA reduction and diabetes type (more pronounced reduction in 
type-2-diabetes, see figure 3). 
• There was no significant impact of depression response on CRP and 
IL-6 levels (see figure 1) as well as on MCP1 and adiponektin levels 
(see figure 4).
C O N C L U S I O N
In the cross-sectional as well as in the longitudinal responder analy-
ses, IL-1RA levels showed a significant association with elevated de-
pression scores as well as with the reduction of depression scores. In 
addition, people with a significant reduction of their depression score 
had a significant lower IL-18 level at follow-up. Besides lifestyle fac-
tors, adherence and glycemic control, systemic inflammatory proces- Figure 4:  Effect sizes of CGM use for avoidance of hypoglycemia in people with and and 
without hypoglycemia ± 95% CI
Figure 2:  Impact of depression response on IL 18 and IL 1 RA levels at 1 year follow-up 
(adjusted for baseline, BMI; age, diabetes type, sex, A1c and medication) 
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M E T H O D S
• At baseline and at the 12 month follow-up 132 people with diabe-
tes and subthreshold depression completed a depression questi-
onnaire (CES-D).
Table 1:  Sample characteristics
Figure 3:  Interaction of depression response and diabetes type on 1 RA levels at 1 year 
follow-up  (adjusted for baseline, BMI; age, sex, A1c and medication)
Figure 1:  Impact of depression response on CRP and IL 6 levels at 1 year follow-up (adjus-
ted for baseline, BMI; age, diabetes type, sex, A1c and medication) 
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• A significant improvement of depression was operationalized as 
a reduction by 9.1 points of the depression score (reliable change 
index). At both measurement points blood samples for the deter-
mination of the systemic inflammatory markers were drawn and 
analyzed in a central laboratory using the same assays and plates 
for baseline as well as for follow-up samples. 
• The multivariate analyses of circulating levels of inflammatory mar-
kers at 1 year follow-up in subjects who showed a significant impro-
vement in depression scores vs. non improvement of depression 
scores were adjusted for the respective baseline of inflammato-
ry marker, age, sex, BMI, HbA1c, diabetes type, macrovascular di-
sease and medication intake (statins, NSAID, anti-coagulant drugs, 
thyroid medication). 
• For the regression and multivariate analyses log-transformed valu-
es of inflammatory markers were used.
ses involving cytokines of the IL-1 family might present a mediating 
mechanism between depression and the prognosis of diabetes.
